Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited)

v3.19.3
Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Net sales $ 183,243 $ 162,970
Cost of sales 64,829 55,367
Gross margin 118,414 107,603
Operating expenses:    
Selling, general and administrative 69,010 67,051
Research and development 16,077 14,789
Total operating expenses 85,087 81,840
Operating income 33,327 25,763
Other (expense) income (15,521) (8,177)
Earnings before income taxes 17,806 17,586
Income taxes 3,408 183
Net earnings 14,398 17,403
Other comprehensive (loss) income:    
Foreign currency translation adjustments (7,602) (1,136)
Unrealized gains (losses) on derivative instruments - cash flow hedges, net of tax of $154 in FY20 (504) 0
Other comprehensive (loss) income (8,106) (1,136)
Comprehensive income $ 6,292 $ 16,267
Earnings per share:    
Basic (in dollars per share) $ 0.38 $ 0.46
Diluted (in dollars per share) $ 0.37 $ 0.45
Weighted average common shares outstanding:    
Basic (in shares) 38,032 37,697
Diluted (in shares) 39,253 38,813